Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors
Theresa Ruf, Rafaela Kramer, Andrea Forschner, Ulrike Leiter, Friedegund Meier, Lydia Reinhardt, P. Dücker, Carolin Ertl, Dirk Tomsitz, Julia K. Tietze, Ralf Gutzmer, Evelyn Dabrowski, Lisa Zimmer, Anja Gesierich, Sarah Zierold, Lars E. French, Thomas Eigentler, Teresa Amaral, Lucie Heinzerling
Topics & Concepts
Immune systemAdverse effectRefractory (planetary science)Second lineMedicineImmune checkpointSteroidOncologyImmunologyFirst lineInternal medicineImmunotherapyBiologyHormoneAstrobiologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesCAR-T cell therapy research